BEMAX
Price
$11.38
Change
+$0.07 (+0.62%)
Updated
Oct 3 closing price
Net Assets
835.41M
RNWAX
Price
$91.42
Change
+$0.31 (+0.34%)
Updated
Oct 3 closing price
Net Assets
75.33B
Interact to see
Advertisement

BEMAX vs RNWAX

Header iconBEMAX vs RNWAX Comparison
Open Charts BEMAX vs RNWAXBanner chart's image
Brandes Emerging Markets Value A
Price$11.38
Change+$0.07 (+0.62%)
VolumeN/A
Net Assets835.41M
American Funds New World R1
Price$91.42
Change+$0.31 (+0.34%)
VolumeN/A
Net Assets75.33B
BEMAX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
BEMAX vs. RNWAX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEMAX is a StrongBuy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 75.3B vs. BEMAX (835M). BEMAX pays higher dividends than RNWAX: BEMAX (2.38) vs RNWAX (0.00). BEMAX was incepted earlier than RNWAX: BEMAX (15 years) vs RNWAX (23 years). RNWAX (1.66) is less costly to investors than BEMAX (1.32). RNWAX is a more actively managed with annual turnover of: 37.00 vs. BEMAX (21.13). RNWAX has a lower initial minimum investment than BEMAX: RNWAX (250) vs BEMAX (2500). BEMAX annual gain was more profitable for investors over the last year : 26.61 vs. RNWAX (12.74). BEMAX return over 5 years is better than : 81.72 vs. RNWAX (29.47).
BEMAXRNWAXBEMAX / RNWAX
Total Expense Ratio1.321.6680%
Annual Report Gross Expense Ratio1.321.6680%
Fund Existence15 years23 years-
Gain YTD38.24724.161158%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets835M75.3B1%
Annual Yield % from dividends2.380.00-
Returns for 1 year26.6112.74209%
Returns for 3 years96.7750.62191%
Returns for 5 years81.7229.47277%
Returns for 10 years112.3590.34124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNPR99.392.18
+2.24%
Monopar Therapeutics Inc
SUPN48.350.39
+0.81%
Supernus Pharmaceuticals
SGI84.240.28
+0.33%
Somnigroup International Inc.
ARTL4.69-0.13
-2.70%
Artelo Biosciences Inc
ZNTL1.61-0.05
-3.01%
Zentalis Pharmaceuticals